Trade Mark Journal No.2021/053 31 December 2021
WO0000001630319 (5,42)
Office of origin: United States of America
Date of International Registration:22 September 2021
Date of designation in the UK:
22 September 2021

- Class 5
- Pharmaceutical preparations for the treatment of genetic disorders.
- Class 42
- Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy.
Shape Therapeutics Inc.
Representative: Michael A. Geller DLA Piper LLP (US), P.O. Box 64807, Chicago IL 60664-0807, UNITED STATES OF AMERICA